Protagonist Therapeutics, Inc. (PTGX) Income Quarterly - Discounting Cash Flows
PTGX
Protagonist Therapeutics, Inc.
PTGX (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2025 (Q3)
09-30
2025 (Q2)
06-30
2025 (Q1)
03-31
2024 (Q4)
12-31
2024 (Q3)
09-30
2024 (Q2)
06-30
2024 (Q1)
03-31
2023 (Q4)
12-31
2023 (Q3)
09-30
2023 (Q2)
06-30
2023 (Q1)
03-31
2022 (Q4)
12-31
2022 (Q3)
09-30
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
2020 (Q3)
09-30
2020 (Q2)
06-30
2020 (Q1)
03-31
2019 (Q4)
12-31
2019 (Q3)
09-30
2019 (Q2)
06-30
2019 (Q1)
03-31
2018 (Q4)
12-31
2018 (Q3)
09-30
2018 (Q2)
06-30
2018 (Q1)
03-31
2017 (Q4)
12-31
2017 (Q3)
09-30
2017 (Q2)
06-30
2017 (Q1)
03-31
2016 (Q4)
12-31
2016 (Q3)
09-30
2016 (Q2)
06-30
2016 (Q1)
03-31
2015 (Q4)
12-31
2015 (Q3)
09-30
2015 (Q2)
06-30
2015 (Q1)
03-31
Report Filing 2025-11-06 2025-11-06 2025-08-06 2025-05-06 2025-02-21 2024-11-07 2024-08-06
1234
Revenue 209.2 4.71 5.55 28.32 170.6 4.67 4.17
1234
Cost of Revenue 0 0 0 0 0 0 0
1234
Gross Profit 209.2 4.71 5.55 28.32 170.6 4.67 4.17
1234
Operating Expenses 190.2 51.13 47.59 47.63 43.86 46.13 42.96
1234
Research & Development 147.8 40 37.04 35.89 34.9 35.97 33.52
1234
Selling, General and Administrative 42.37 11.13 10.55 11.74 8.95 10.16 9.44
1234
Other Operating Expenses 0 0 0 0 0 0 0
1234
Operating Income 19.01 -46.42 -42.04 -19.31 126.8 -41.45 -38.79
1234
Net Non-Operating Interest 28.88 7.05 7.41 7.57 6.85 7.68 7.4
1234
Interest Income 28.88 7.05 7.41 7.57 6.85 7.68 7.4
1234
Interest Expense 0 0 0 0 0 0 0
1234
Equity & Other Income/(Expense) 0.182 0.033 0.036 0.082 0.031 0.141 0.097
1234
Income Before Tax 48.07 -39.34 -34.6 -11.65 133.7 -33.63 -31.29
1234
Income Tax Expense 2.16 0 0.172 0 1.99 -0.42 -0.676
1234
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0 0
1234
Net Income 45.91 -39.34 -34.77 -11.65 131.7 -33.21 -30.62
1234
Depreciation and Amortization 1.44 0.361 0.304 0.239 0.536 0.647 1.48
1234
EBITDA 20.45 -46.06 -41.74 -19.07 127.3 -40.81 -37.32
1234
Earnings Per Share (EPS) 0.75 -0.62 -0.55 -0.19 2.11 -0.54 -0.5
1234
Diluted Earnings Per Share 0.62 -0.62 -0.55 -0.19 1.98 -0.54 -0.5
1234
Weighted Average Shares Outstanding 63.77 63.77 63.51 62.96 62.33 61.77 61.31
1234
Diluted Weighted Average Shares Outstanding 63.77 63.77 63.51 62.96 66.41 61.77 61.31
1234
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program